"Dallas Nephrology Associates (DNA) is a national leader in providing comprehensive care for patients with kidney disease, kidney transplant, and hypertension."

During the past decade, Dallas Transplant Institute conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Dallas Transplant Institute" are "Kidney Transplantation" (2 trials). Many other conditions were trialed in "Dallas Transplant Institute" in a lesser frequency.

Most popular intervention types in "Dallas Transplant Institute" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "CP-690,550" (2 trials), "Cyclosporine" (1 trials) and "Tacrolimus" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dallas Transplant Institute" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Dallas Transplant Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Dallas Transplant Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Dallas Transplant Institute, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".